AstraZeneca headquarters new global research and development facility, named The Discovery Centre (DISC) in Cambridge, UK, on the Cambridge Biomedical Campus (CBC). As part of the wider development known as the Cambridge Southern Fringe Area, CBC is envisioned as a future leading centre for biomedical research and development with institutions and companies from the education, health care, science and research sectors.
Cambridge, one of the most exciting bioscience hotspots in the world, is home to the largest UK research and development centre – The DISC. Here more than 2,300 scientists work in drug discovery and development, across our therapy areas, each playing a central role in our mission to deliver life-changing medicines to patients. The DISC is uniquely designed to strengthen collaboration, promote openness, and improve the sustainability of every aspect of our science and our business operations.
The DISC represents the belief in what science can do. It enables scientists to discover new medicines more efficiently and deliver them more effectively, harnessing the power of data and artificial intelligence, digital technologies and novel precision medicine approaches.
By working with our neighbours and driving a convergence of innovation, collaboration and talent from the heart of the Cambridge Biomedical Campus and beyond, we continue to develop our culture and accelerate the science in our key therapy areas of Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology and rare diseases.
Susan GalbraithExecutive Vice-President, Oncology R&D, AstraZeneca
